G MEDICAL RECEIVES CONDITIONAL PURCHASE ORDER FROM ZINGMOBILE FOR PRIZMA MEDICAL SMARTPHONE CASE
Announcement posted by G Medical Innovations 03 May 2018
Conditional Purchase Order valued at US$3m and covers 11 Asian markets including Singapore
Mobile and e-Health company G Medical Innovations (ASX: GMV) is pleased to announce that it has received a conditional purchase order of its Prizma Medical Smartphone Case from Zingmobile, a leading mobile platform enabler in the Asia-Pacific, based in Singapore.
The conditional purchase order is valued at US$3m and is for units that intend to be sold in Singapore and 10 other markets in South East Asia, including The Philippines, Malaysia, Thailand and Indonesia.
Under the terms of this purchase order, Zingmobile will also become a distributor for G Medical Innovations in these territories moving forward.
The purchase order is conditional on receiving regulatory certifications clearance and local carrier approval for each individual country, and the ability for Zingmobile to work with G Medical Innovations on translating and localising the user interface of the Prizma.
The Conditional PO will expire on May 1, 2019, if the above conditions are not met by the parties.
Today’s announcement continues the ongoing commercialisation of the Prizma, and comes off the back of initial purchase orders being fulfilled as well as the launch of the global online store that makes the Prizma available to consumers globally for the very first time.
The Prizma has received approvals from regulatory authorities such as the FDA and TGA, and has also been approved for CE marking. The device is able to monitor a range of biometric measurements with the ability to provide and transmit real-time results and present medical data to detect trends over time.
G Medical CEO Dr. Yacov Geva said, “Today’s conditional purchase order with Zingmobile opens up key Asian markets and delivers us an important strategic partner in the region, to a part of the world with a population of more than 798 million, giving us further opportunity to realise our vision of transforming healthcare.”
Otsana Capital
108 Outram Street
West Perth WA 6005
Telephone: +61 8 9486 7244
www.otsana.com
About G Medical Innovations
G Medical (ASX:GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company brings forth the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity.
The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.
For more information on G Medical, please visit www.gmedinnovations.com
For investor enquiries or feedback for the Company that are not related to your shareholding, email investors@gmedinnovations.com
The conditional purchase order is valued at US$3m and is for units that intend to be sold in Singapore and 10 other markets in South East Asia, including The Philippines, Malaysia, Thailand and Indonesia.
Under the terms of this purchase order, Zingmobile will also become a distributor for G Medical Innovations in these territories moving forward.
The purchase order is conditional on receiving regulatory certifications clearance and local carrier approval for each individual country, and the ability for Zingmobile to work with G Medical Innovations on translating and localising the user interface of the Prizma.
The Conditional PO will expire on May 1, 2019, if the above conditions are not met by the parties.
Today’s announcement continues the ongoing commercialisation of the Prizma, and comes off the back of initial purchase orders being fulfilled as well as the launch of the global online store that makes the Prizma available to consumers globally for the very first time.
The Prizma has received approvals from regulatory authorities such as the FDA and TGA, and has also been approved for CE marking. The device is able to monitor a range of biometric measurements with the ability to provide and transmit real-time results and present medical data to detect trends over time.
G Medical CEO Dr. Yacov Geva said, “Today’s conditional purchase order with Zingmobile opens up key Asian markets and delivers us an important strategic partner in the region, to a part of the world with a population of more than 798 million, giving us further opportunity to realise our vision of transforming healthcare.”
-ENDS-
Corporate Advisors Otsana Capital
108 Outram Street
West Perth WA 6005
Telephone: +61 8 9486 7244
www.otsana.com
About G Medical Innovations
G Medical (ASX:GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company brings forth the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity.
The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.
For more information on G Medical, please visit www.gmedinnovations.com
For investor enquiries or feedback for the Company that are not related to your shareholding, email investors@gmedinnovations.com